ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,000 | +8.5% | 850 | -33.1% | 0.00% | – |
| Q3 2019 | $47,000 | -20.3% | 1,271 | 0.0% | 0.00% | – |
| Q2 2019 | $59,000 | +25.5% | 1,271 | +9.7% | 0.00% | – |
| Q1 2019 | $47,000 | +6.8% | 1,159 | +22.4% | 0.00% | – |
| Q4 2018 | $44,000 | +51.7% | 947 | +44.4% | 0.00% | – |
| Q3 2018 | $29,000 | +1350.0% | 656 | +941.3% | 0.00% | – |
| Q2 2018 | $2,000 | -97.1% | 63 | -93.5% | 0.00% | -100.0% |
| Q1 2018 | $70,000 | +233.3% | 975 | +203.7% | 0.00% | – |
| Q4 2017 | $21,000 | +23.5% | 321 | 0.0% | 0.00% | – |
| Q3 2017 | $17,000 | +750.0% | 321 | +817.1% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 35 | -82.5% | 0.00% | – |
| Q4 2016 | $3,000 | -98.5% | 200 | -98.6% | 0.00% | -100.0% |
| Q3 2016 | $200,000 | +42.9% | 14,437 | +0.6% | 0.01% | +25.0% |
| Q2 2016 | $140,000 | – | 14,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |